Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
Fundamentals
Mkt Cap
$4.63M
Volume
-
52W High
$5.87
52W Low
$0.9509
PE Ratio
-0.26
Avg. Volume
2.08M
EPS (Annual)
-$8.16
P/B
1.33
Rev/Employee
$0.00
Earnings
Aug 11
49
Neutral Sentiment
How do you feel about DRMA?
brallt
$DRMA The organic growth is strong. The slow grind and lack of trapped longs fighting for exit, has a certain apeal to it. Has a large chance to see 2$+ soon.
1
martyn78
Been tapped into for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍
$DRMA & $GDHG I like them-